The global vessel sealing devices market size was estimated at USD 19.98 billion in 2024 and is projected to be worth around USD 37.86 billion by 2034, growing at a CAGR of 6.6% from 2025 to 2034.
Highlights of the Vessel Sealing Devices Market
- By product, the instruments segment underwent notable growth in the market during 2024.
- By product, the accessories segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
- By technology, the bipolar segment captured a significant portion of the market in 2024.
- By technology, the ultrasonic segment is projected to experience the highest growth rate in the market between 2025 and 2034.
- By application, the laparoscopic surgery segment enjoyed a prominent position in the vessel sealing devices market during 2024.
- By application, the general surgery segment is set to experience the fastest rate of market growth from 2025 to 2034.
- By end use, the hospitals segment maintained its leading position in the market in 2024.
- By end use, the ambulatory surgical centers segment is anticipated to grow with the highest CAGR in the market during the studied years.
- By region, North America dominated the global vessel sealing devices market in 2024.
- By region, Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.
Industry Valuation and Growth Rate Projection
| Industry Worth |
Details |
| Market Size in 2025 |
USD 21.3 Billion |
| Market Size by 2034 |
USD 37.86 Billion |
| Market Growth Rate from 2025 to 2034 |
CAGR of 6.6% |
Vessel sealing devices are medical devices that use bipolar electrothermal energy to seal blood vessels by denaturing collagen. Vessel sealing devices are defined as a medical device that uses bipolar electrothermal energy to seal blood vessels by denaturing collagen and elastin in the vessel wall, effectively occluding the vessel and reducing blood loss during surgical procedures like liver parenchyma division. The benefits of vessel sealing devices include improved patient outcomes, reduced risk of complications, ergonomic design for improved handling and comfort, advanced energy delivery systems for accurate control, and feedback mechanisms to ensure reliable sealing. Rising awareness regarding the advantages offered by vessel sealing devices, rising prevalence of chronic diseases, technological innovation in vessel sealing devices, and rising demand for minimally invasive surgery are driving the growth of the vessel sealing devices market.
- In April 2025, the Hemopatch Sealing Hemostat, a room temperature collagen pad approved for Hemostasis and Sealing, was launched by Baxter. The Hemopatch Sealing Hemostat is a ready-to-use, absorbable collagen pad for open surgery and minimally invasive surgical procedures (MIS), improving the surgical toolkit for healthcare professionals.
Vessel Sealing Devices: Stats & Figures
- In September 2021, the global launch of the CoolSeal Vessel Sealing Platform was announced by Bolder Surgical. CoolSeal has been in use since October 2020 in the U.S., and with the new international regulatory approvals, the devices are available in over 20 countries around the world.
- In June 2021, the launch of the ENSEAL X1 Curved Jaw Tissue Sealer, a new advanced bipolar energy device that increases procedural efficiency and provides stronger sealing and better access to more tissue than LigaSure Maryland, was announced by Ethicon, a part of Johnson & Johnson Medical Devices Company.
Growth Factors
Technological innovation in vessel sealing devices: Newly developed vessel sealing devices build upon bipolar diathermy and also ultrasonic technology to provide more consistent hemostasis with increased efficiency and added functionality. The advanced bipolar and ultrasonic devices that seal vessels via analogous thermal processes, resulting in tissue desiccation. Laparoscopic vessel sealing devices have transformed modern laparoscopy. Energy-based sealing technologies, like ultrasonic and electrosurgical sealing technologies, offer accurate control over vessel sealing, allowing surgeons to carry out critical procedures with greater confidence and improved outcomes.
Rising demand for minimally invasive surgery: For procedures such as laparoscopy, endoscopy, and endovascular surgery, surgeons use many ways to operate with less damage to the body than with open surgery. Minimally invasive surgery offers less pain, shorter hospital stays, and fewer complications. It also includes benefits of lower infection risks, smaller scars, less pain, and faster recovery. It is an excellent option for many procedures, allowing patients to return to normal activities quicker with fewer complications.
Market Restraint
- Supply chain disruptions: The main reasons for supply chain disruptions are cyberattacks, adverse weather, interruptions in the transport network, lack of skilled labor, and more. Supply chain disruptions can lead to increased costs because of lost sales, high-priced last-minute suppliers, and expedited shipping. Freight costs can lead to many issues in order to maintain production, like the need to switch from economical sea freight to expensive air freight. Supply chain may include increased complexity, financial uncertainties, reputational risks, loss of quality control, compliance issues, wasted resources, resource mix-ups, and longer delivery times.
Market Opportunity
- Investing in research and development: Research into new technology is expected to lead to massive innovation in the business. This may be in terms of new products and services, enhanced processes, and new ways to interact with customers. These innovations can result in lower costs and greater profits. Innovation is a useful way to grow a business. Investing in research and development efforts drives innovation, improves competitive benefits, facilitates market expansion, and contributes to sustainable development.
Segmental Insights
Product Insights
The instruments segment underwent notable growth in the vessel sealing devices market during 2024. Vessel sealing instruments are a medical device that uses bipolar electrothermal energy to seal blood vessels by denaturing collagen and elastin in the vessel wall, effectively occluding the vessel and reducing the blood loss during surgical procedures like liver parenchyma division.
The accessories segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034. Vessel sealing accessories refer to a group of specialized instruments and gadgets that are used during the time of sealing and cutting blood vessels efficiently and effectively. These surgical accessories are essential in various medical specialties like laparoscopy, urology, gynecology, and general surgery.
Technology Insights
The bipolar segment captured a significant portion of the vessel sealing devices market in 2024. Bipolar sealer is a sterile, single-use, electrosurgical device used in combination with a pump generator to deliver radiofrequency (RF) energy and saline for the hemostatic sealing and coagulation of soft tissues and bones at the operative site to prevent surgery-related blood loss.
The ultrasonic segment is projected to experience the highest growth rate in the market between 2025 and 2034. Ultrasonic surgical devices provide low smoke generation, minimal lateral thermal damage, efficient transection, excellent hemostasis, less packing waste, and no risk of electrical current passage to the patient.
Application Insights
The laparoscopic surgery segment enjoyed a prominent position in the vessel sealing devices market during 2024. The benefits of laparoscopic surgery include reduced risk of infections, quick healing as the scar is small, getting back to normal life sooner, less pain while the scar heals, less use of pain medications, less tissue cutting, staying fewer days in the hospital, and very small scars.
The general surgery segment is set to experience the fastest rate of market growth from 2025 to 2034. In general, surgery benefits include improved patient outcomes with minimally invasive technologies, reduced pain and discomfort, and reduced recovery and healing time.
End-use Insights
The hospitals segment maintained its leading position in the vessel sealing devices market in 2024. The hospital is a conducive place for people who need treatment for their illness. It also plays an important role in the community. The hospital is staffed, built, and equipped for the diagnosis of disease, for treatment, both medical and surgical, of the sick and the injured for their housing during this process.
The ambulatory surgical centers segment is anticipated to grow with the highest CAGR in the market during the studied years. Ambulatory surgical centers (ASCs) are designed with patient convenience in mind. These centers may offer more flexible scheduling, enabling patients to undergo procedures at times that are convenient for them. These centers operate exclusively for the purpose of providing surgical services to patients who do not require hospitalization and whose expected duration of services does not require to exceed 24 hours.
Geographical Insights
North America dominated the global vessel sealing devices market in 2024. Strict regulatory standards, collaborations & partnerships, integration of complex devices, high level of surgical proficiency, and availability of advanced healthcare system facilities are driving the growth of the market in the North American region.
Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period. Industrial modernization in key economies, rising investment in automation and sustainability, government incentives for industrial digitization, and investing in research and development are contributing to the growth of the vessel sealing devices market in the Asia Pacific region.
Recent Developments in the Vessel Sealing Devices Market
- In November 2024, the U.S. Food and Drug Administration (FDA) 510(k) clearance for the LigaSure Maryland jaw open/laparoscopic sealer/divider was received by expanding the vessel and tissue sealing portfolio, Covidien. Covidien will launch the device in the United States and the European Union. The device is designed for minimally invasive procedures, including vascular, urologic, thoracic and thoracoscopic, and gynecologic procedures where ligation and division of the vessels is performed.
- In September 2022, the ThunderBeat Open Fine Jaw Type X surgical energy device for open surgery was introduced by Olympus. This device is a single-use ultrasonic and bipolar electrosurgical instrument that has been designed for open surgical procedures needing dissection of delicate and fine tissues, like thyroidectomy or radical neck dissection.
Vessel Sealing Devices Market Share, By Region, 2024 (%)
| Regions |
Shares (%) |
| North America |
35% |
| Asia Pacific |
30% |
| Europe |
25% |
| LAMEA |
10% |
- North America – Holds 35% of the 2024 market, supported by high surgical volumes and advanced healthcare systems. Dominates due to strong adoption of cutting-edge surgical technologies and high healthcare spending.
- Asia Pacific – Accounts for 30% of the 2024 market, driven by expanding healthcare infrastructure. Gaining momentum as surgical procedure volumes grow and minimally invasive techniques become more widespread.
- Europe – Holds 25% of the 2024 market, sustained by strong regulatory standards and advanced surgical practices. Does not dominate due to comparatively slower equipment replacement cycles.
- LAMEA – Represents 10% of the 2024 market, covering emerging healthcare economies. Does not dominate due to limited access to advanced surgical systems and lower per-capita health expenditure.
Vessel Sealing Devices Market Share, By Product, 2024 (%)
| Segments |
Shares (%) |
| Instruments |
55% |
| Generators |
30% |
| Accessories |
15% |
- Instruments – Holds 55% of the 2024 market, representing core vessel sealing tools used across most surgical procedures. Dominates due to high usage frequency, reliability, and continuous innovation in energy-based sealing technologies.
- Generators – Accounts for 30% of the 2024 market, powering energy-based instruments during surgical procedures. Gaining momentum as hospitals upgrade to advanced, multifunctional energy platforms.
- Accessories – Represents 15% of the 2024 market, covering consumables and supplementary components. Does not dominate due to their secondary role and lower revenue contribution compared to instruments and generators.
Vessel Sealing Devices Market Share, By Technology, 2024 (%)
| Segments |
Shares (%) |
| Bipolar |
40% |
| Ultrasonic |
30% |
| Monopolar |
20% |
| Hybrid |
10% |
- Bipolar – Holds 40% of the 2024 market, offering precise vessel sealing with reduced thermal spread. Dominates because it is widely adopted, cost-effective, and well-established in both open and minimally invasive surgeries.
- Ultrasonic – Accounts for 30% of the 2024 market, providing efficient cutting and sealing with minimal tissue damage. Gaining momentum as surgeons prefer enhanced precision and improved surgical outcomes.
- Monopolar – Represents 20% of the 2024 market, used primarily for basic electrosurgical functions. Does not dominate due to higher thermal spread and rising preference for safer, more advanced modalities.
- Hybrid – Holds 10% of the 2024 market, integrating ultrasonic and bipolar benefits. Gaining momentum as healthcare facilities shift toward advanced multifunctional sealing systems.
Vessel Sealing Devices Market Share, By Application, 2024 (%)
| Segments |
Shares (%) |
| Laparoscopic surgery |
65% |
| General surgery |
35% |
- Laparoscopic surgery – Accounts for 65% of the 2024 market, driven by minimally invasive surgical adoption. Dominates due to rising preference for MIS procedures offering reduced recovery time and lower complication risks.
- General surgery – Holds 35% of the 2024 market, covering open and routine procedures. Does not dominate as the shift toward minimally invasive approaches grows globally.
Vessel Sealing Devices Market Share, By End Use, 2024 (%)
| Segments |
Shares (%) |
| Hospitals |
60% |
| Ambulatory surgical centers |
20% |
| Specialty clinics |
10% |
| Other end use |
10% |
- Hospitals – Holds 60% of the 2024 market, serving as the primary centers for complex surgical procedures. Dominates due to higher procedure volume, availability of advanced equipment, and greater capital investment.
- Ambulatory surgical centers – Accounts for 20% of the 2024 market, focusing on outpatient surgeries. Gaining momentum as MIS procedures increase and lower-cost care settings expand.
- Specialty clinics – Represents 10% of the 2024 market, catering to focused surgical treatments. Does not dominate due to limited procedure volume and narrower service scope.
- Other end use – Holds 10% of the 2024 market, including smaller facilities and niche centers. Does not dominate owing to restricted infrastructure and lower equipment adoption.
